(GERN:Consolidated Issue Listed on NASDAQ Global Select )
Hoyoung Huh M.D., Ph.D.
Chairman and Member of Nominating & Corporate Governance Committee, Geron Corporation
|Age||Total Calculated Compensation||This person is connected to 111 board members in 8 different organizations across 11 different industries.|
See Board Relationships
Dr. Hoyoung Huh, M.D., Ph.D. serves as Managing Director of Konus Advisory Group. Dr. Huh serves as an Advisor at Bay City Capital LLC and focuses on emerging markets and Japan. Prior to founding Konus, Dr. Huh served as the Chief Executive Officer and President at BiPar Sciences, Inc. from March 3, 2008 to December 1, 2009. Dr. Huh served as the Chief Operating Officer and Head of the PEGylation Business Unit of Nektar Therapeutics from May 2007 to February 29, 2008 ...
149 Commonwealth DrivePhone: 650-473-7700
Menlo Park, California 94025
Board Members Memberships*
Chairman and Chairman of BiPar Innovation Board
Former Director, Member of Audit Committee, Member of Compensation Committee and Member of Scientific Review Committee
Chairman and Member of Nominating & Corporate Governance Committee
Chairman of The Board
Chairman of Scientific Advisory Board and Director
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|